Opendata, web and dolomites

MetaboliQs SIGNED

Leveraging room temperature diamond quantum dynamics to enable safe, first-of-its-kind, multimodal cardiac imaging

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MetaboliQs project word cloud

Explore the words cloud of the MetaboliQs project. It provides you a very rough idea of what is the project "MetaboliQs" about.

zurich    diamond    companies    circumstances    disease    commercializing    confidently    trials    diagnose    vacancy    pet    globally    breakthrough    molecular    nvision    magnetic    paramagnetic    fabrication    people    institutes    therapeutics    grade    hyperpolarized    characterization    nv    tomography    resonance    treatment    fraunhofer    leader    class    medical    brings    cvds    tools    expertise    personalize    excellence    worldwide    newly    care    tissue    patients    emission    quantum    innovative    cvd    iaf    continental    personalized    first    appropriate    metaboliqs    mri    diseases    chemical    dynamics    death    conduct    imaging    tum    select    cardiovascular    market    sensing    eth    metabolic    preclinical    hyperpolarization    precision    world    therapy    realizing    unachievable    difficult    unaddressed    positron    sensitive    annually    nitrogen    bruker    unmet    die    translate    clinical    synthetic    previously    expert    centers    accurately    huji    paving    electron    quantification    despite    diagnostics    polarization    multidisciplinary    outcomes    inventor    diamonds   

Project "MetaboliQs" data sheet

The following table provides information about the project.

Coordinator
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. 

Organization address
address: HANSASTRASSE 27C
city: MUNCHEN
postcode: 80686
website: www.fraunhofer.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 6˙667˙801 €
 EC max contribution 6˙667˙801 € (100%)
 Programme 1. H2020-EU.1.2.3. (FET Flagships)
 Code Call H2020-FETFLAG-2018-03
 Funding Scheme RIA
 Starting year 2018
 Duration (year-month-day) from 2018-10-01   to  2021-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. DE (MUNCHEN) coordinator 1˙500˙172.00
2    NVISION IMAGING TECHNOLOGIES GMBH DE (ULM) participant 1˙430˙937.00
3    KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN DE (MUENCHEN) participant 1˙220˙401.00
4    ELEMENT SIX (UK) LIMITED UK (HARWELL OXFORDSHIRE DIDCOT) participant 960˙290.00
5    EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH CH (ZUERICH) participant 936˙812.00
6    THE HEBREW UNIVERSITY OF JERUSALEM IL (JERUSALEM) participant 390˙387.00
7    BRUKER BIOSPIN GMBH DE (RHEINSTETTEN) participant 228˙800.00

Map

 Project objective

Cardiovascular Diseases (CVDs) are the number 1 cause of death globally: more people die annually from CVDs than from any other cause. Despite emerging diagnostics tools and therapeutics, several areas of significant unmet need remain unaddressed among CVD patients. The ability to personalize cardiovascular medical care and improve outcomes, will require characterization of disease processes at a molecular level. The current state-of-the-art, e.g., Positron emission tomography (PET), does not provide detailed information about the chemical state of the tissue at a molecular level, therefore it remains difficult to accurately diagnose and confidently select appropriate therapy in many circumstances. The MetaboliQs project brings together two areas of European excellence - diamond-based quantum sensing and medical imaging. We will translate a newly developed hyperpolarization method for magnetic resonance imaging (MRI) based on the quantum dynamics of nitrogen-vacancy (NV) centers. This breakthrough quantum technology will enable previously unachievable, highly sensitive quantification of metabolic activity, paving the way for precision diagnostics and better personalized treatment of cardiovascular and other metabolic diseases. For realizing and eventually commercializing the technology, MetaboliQs brings together a world-class multidisciplinary consortium with end to end expertise - leading diamond quantum technology research institutes (Fraunhofer IAF - quantum-grade diamond growth and fabrication, HUJI - quantum sensing) and innovative companies (Element 6 - worldwide leader in synthetic diamonds, NVision - inventor of diamond-based polarization), as well as two expert users of hyperpolarized and cardiovascular MRI (TUM, ETH Zurich - first in continental Europe to conduct clinical trials of hyperpolarized MRI for cardiovascular disease) and the market leader in electron paramagnetic resonance and preclinical MRI (Bruker).

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "METABOLIQS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "METABOLIQS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.2.3.)

S2QUIP (2018)

Scalable Two-Dimensional Quantum Integrated Photonics

Read More  

FLAG-ERA III (2018)

The Flagship ERA-NET — FLAG-ERA III

Read More  

SQUARE (2018)

Scalable Rare Earth Ion Quantum Computing Nodes

Read More